Our BD Director, Ting-Wan, will present as an invited expert speaker at 3rd Annual CAR-TCR Cell Therapy Summit Asiain Singapore (November 12-14, 2024) - GenomeFrontier Therapeutics, Inc. 先驅生技

Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific communication, Marcus J. Calkins, will present our work as invited expert speakers at the 9th Annual CAR-TCR Summit in Boston, US. (September 17-20, 2024)

台灣食藥署(TFDA)已核准先驅生技提交的GF-CART01臨床試驗申請(IND)，該療法為針對血液型B細胞惡性腫瘤的CD20/CD19雙標靶CAR-T細胞治療！

發佈留言取消回覆